Immune-glutamatergic dysfunction as a central mechanism of the autism spectrum disorders.

Despite the great number of observations being made concerning cellular and the molecular dysfunctions associated with autism spectrum disorders (ASD), the basic central mechanism of these disorders has not been proposed in the major scientific literature. Our review brings evidence that most heterogeneous symptoms of ASD have a common set of events closely connected with dysregulation of glutamatergic neurotransmission in the brain with enhancement of excitatory receptor function by pro-inflammatory immune cytokines as the underlying mechanism. We suggest that environmental and dietary excitotoxins, mercury, fluoride, and aluminum can exacerbate the pathological and clinical problems by worsening excitotoxicity and by microglial priming. In addition, each has effects on cell signaling that can affect neurodevelopment and neuronal function. Our hypothesis opens the door to a number of new treatment modes, including the nutritional factors that naturally reduce excitotoxicity and brain inflammation.

[1]  Guy C. Brown,et al.  Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria , 2003, Molecular Neurobiology.

[2]  Mark von Zastrow,et al.  Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD , 2000, Nature Neuroscience.

[3]  S. Amara,et al.  Excitatory amino acid transporters: a family in flux. , 1999, Annual review of pharmacology and toxicology.

[4]  P. Wong,et al.  Deficits in Water Escape Performance and Alterations in Hippocampal Cholinergic Mechanisms Associated With Neonatal Monosodium Glutamate Treatment in Mice , 1997, Pharmacology Biochemistry and Behavior.

[5]  T. Serikawa,et al.  Separation of Antiepileptogenic and Antiseizure Effects of Levetiracetam in the Spontaneously Epileptic Rat (SER) , 2005, Epilepsia.

[6]  O. Lindvall,et al.  Inflammation is detrimental for neurogenesis in adult brain , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A Anthony,et al.  Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children (Retracted article. See vol 375, pg 445, 2010) , 1998 .

[8]  G. Blatt,et al.  Increased GAD67 mRNA expression in cerebellar interneurons in autism: Implications for Purkinje cell dysfunction , 2008, Journal of neuroscience research.

[9]  J. Berman,et al.  Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat , 2011, Journal of NeuroVirology.

[10]  P. Brachet,et al.  1,25 Dihydroxyvitamin D3 Exerts Regional Effects in the Central Nervous System during Experimental Allergic Encephalomyelitis , 1996, Journal of neuropathology and experimental neurology.

[11]  T P Stein,et al.  Increased excretion of a lipid peroxidation biomarker in autism. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[12]  M. Sakamoto,et al.  Comparison of mercury accumulation among the brain, liver, kidney, and the brain regions of rats administered methylmercury in various phases of postnatal development , 1995, Bulletin of environmental contamination and toxicology.

[13]  P. Thuras,et al.  Purkinje Cell Size Is Reduced in Cerebellum of Patients with Autism , 2002, Cellular and Molecular Neurobiology.

[14]  N. Saunders,et al.  Acute-phase cytokines IL-1beta and TNF-alpha in brain development. , 2000, Cell and tissue research.

[15]  M. State,et al.  Recent Advances in the Genetics of Autism , 2007, Biological Psychiatry.

[16]  J. G. Netzeband,et al.  Chronic Interleukin-6 Alters NMDA Receptor-Mediated Membrane Responses and Enhances Neurotoxicity in Developing CNS Neurons , 1998, The Journal of Neuroscience.

[17]  J. Olney,et al.  New insights and new issues in developmental neurotoxicology. , 2002, Neurotoxicology.

[18]  M. Spence,et al.  A case of autism with an interstitial deletion on 4q leading to hemizygosity for genes encoding for glutamine and glycine neurotransmitter receptor sub-units (AMPA 2, GLRA3, GLRB) and neuropeptide receptors NPY1R, NPY5R , 2004, BMC Medical Genetics.

[19]  F. Gage,et al.  Reduced Hippocampal Neurogenesis in Adult Transgenic Mice with Chronic Astrocytic Production of Interleukin-6 , 2002, The Journal of Neuroscience.

[20]  B. Schilter,et al.  Increased vulnerability of neurones and glial cells to low concentrations of methylmercury in a prooxidant situation , 1998, Acta Neuropathologica.

[21]  J. Xuereb,et al.  The messenger RNAs for the N-methyl- d-aspartate receptor subunits show region-specific expression of different subunit composition in the human brain , 1996, Neuroscience.

[22]  A. Novelli,et al.  Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced , 1988, Brain Research.

[23]  H. L. Wong,et al.  Patterns of Complementary and Alternative Medical Therapy Use in Children Diagnosed with Autism Spectrum Disorders , 2006, Journal of autism and developmental disorders.

[24]  F. Nicoletti,et al.  Molecular determinants of metabotropic glutamate receptor signaling. , 2001, Trends in pharmacological sciences.

[25]  T. Hayashi,et al.  Vitamin D3 attenuates cortical infarction induced by middle cerebral arterial ligation in rats , 2000, Neuropharmacology.

[26]  T. Bourgeron,et al.  Linkage and association of the glutamate receptor 6 gene with autism , 2002, Molecular Psychiatry.

[27]  S. Shanker,et al.  Guidelines for Early Identification, Screening, and Clinical Management of Children With Autism Spectrum Disorders , 2008, Pediatrics.

[28]  D. Geier,et al.  A clinical trial of combined anti-androgen and anti-heavy metal therapy in autistic disorders. , 2006, Neuro endocrinology letters.

[29]  Geraldine Dawson,et al.  Head circumference and height in autism: A study by the collaborative program of excellence in autism , 2006, American journal of medical genetics. Part A.

[30]  Kuldip Singh,et al.  Studies on the effect of monosodium glutamate [MSG] administration on some antioxidant enzymes in the arterial tissue of adult male mice. , 2003, Journal of nutritional science and vitaminology.

[31]  W. Brown,et al.  Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin--the antioxidant proteins. , 2004, Life sciences.

[32]  S. U. Kim,et al.  Methylmercury-induced neurotoxicity in cerebral neuron culture is blocked by antioxidants and NMDA receptor antagonists. , 1996, Neurotoxicology.

[33]  T. Stone,et al.  Enhanced neuronal damage by co‐administration of quinolinic acid and free radicals, and protection by adenosine A2A receptor antagonists , 2002, British journal of pharmacology.

[34]  Ruth A. Carper,et al.  Inverse correlation between frontal lobe and cerebellum sizes in children with autism. , 2000, Brain : a journal of neurology.

[35]  R. Yokel,et al.  Aluminum bioavailability from the approved food additive leavening agent acidic sodium aluminum phosphate, incorporated into a baked good, is lower than from water. , 2006, Toxicology.

[36]  Seithikurippu R. Pandi-Perumal,et al.  Dim light melatonin onset (DLMO): A tool for the analysis of circadian phase in human sleep and chronobiological disorders , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[37]  Salvatore Mazza,et al.  Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: An overview , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[38]  P. Rakic,et al.  Modulation of neuronal migration by NMDA receptors. , 1993, Science.

[39]  Daniela C. Zarnescu,et al.  Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila. , 2008, Nature chemical biology.

[40]  J. Olney,et al.  GLUTAMATE‐INDUCED BRAIN DAMAGE IN INFANT PRIMATES , 1972, Journal of neuropathology and experimental neurology.

[41]  G. Blatt,et al.  Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications , 2007, Acta Neuropathologica.

[42]  M. Bear,et al.  Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome , 2008, The Journal of physiology.

[43]  A. Wakefield,et al.  Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. , 1998, Lancet.

[44]  Colm Cunningham,et al.  The impact of systemic infection on the progression of neurodegenerative disease , 2003, Nature Reviews Neuroscience.

[45]  P. Ashwood,et al.  Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms , 2006, Journal of Neuroimmunology.

[46]  Y. Adachi,et al.  β‐Glucan Derived from Zymosan Acts as an Adjuvant for Collagen‐Induced Arthritis , 2006 .

[47]  C. Rice.  Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. , 2009, Morbidity and mortality weekly report. Surveillance summaries.

[48]  N. Brookes.  Specificity and Reversibility of the Inhibition by HgCl2 of Glutamate Transport in Astrocyte Cultures , 1988, Journal of neurochemistry.

[49]  B. Frieder,et al.  Prenatal monosodium glutamate (MSG) treatment given through the mother's diet causes behavioral deficits in rat offspring. , 1984, The International journal of neuroscience.

[50]  R. Landa,et al.  Lamotrigine Therapy for Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial , 2001, Journal of autism and developmental disorders.

[51]  J. Luke,et al.  Fluoride Deposition in the Aged Human Pineal Gland , 2001, Caries Research.

[52]  Ruth A. Carper,et al.  Autism and Abnormal Development of Brain Connectivity , 2004, The Journal of Neuroscience.

[53]  Y. Ohno,et al.  Chronic vitamin D3 treatment protects against neurotoxicity by glutamate in association with upregulation of vitamin D receptor mRNA expression in cultured rat cortical neurons , 2006, Journal of neuroscience research.

[54]  M. L. Martinez,et al.  Methylmercury increases glutamate extracellular levels in frontal cortex of awake rats. , 2002, Neurotoxicology and teratology.

[55]  A. Akaike,et al.  Protective effects of a vitamin B12 analog, methylcobalamin, against glutamate cytotoxicity in cultured cortical neurons. , 1993, European journal of pharmacology.

[56]  K. Schlett.  Glutamate as a modulator of embryonic and adult neurogenesis. , 2006, Current topics in medicinal chemistry.

[57]  C. McDougle,et al.  Neurochemistry in the pathophysiology of autism. , 2005, The Journal of clinical psychiatry.

[58]  M. Slaughter,et al.  A non-excitatory paradigm of glutamate toxicity. , 2002, Journal of neurophysiology.

[59]  Christopher Gillberg,et al.  Genome-Wide Scan for Autism Susceptibility Genes , 1999 .

[60]  N. Saunders,et al.  Acute-phase cytokines IL-1β and TNF-α in brain development , 2000, Cell and Tissue Research.

[61]  A. Zimmerman,et al.  Neuroglial activation and neuroinflammation in the brain of patients with autism , 2005, Annals of neurology.

[62]  A. Campbell.  The role of aluminum and copper on neuroinflammation and Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.

[63]  H. Kettenmann,et al.  Physiology of microglial cells , 2005, Brain Research Reviews.

[64]  R. Tuchman,et al.  Regression in pervasive developmental disorders: seizures and epileptiform electroencephalogram correlates. , 1997, Pediatrics.

[65]  E. Faustman,et al.  The role of intracellular glutathione in methylmercury-induced toxicity in embryonic neuronal cells. , 1999, Neurotoxicology.

[66]  Yoshio Minabe,et al.  Increased serum levels of glutamate in adult patients with autism , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[67]  B. H. Choi.  The effects of methylmercury on the developing brain , 1989, Progress in Neurobiology.

[68]  M. Carlsson,et al.  Hypothesis: Is infantile autism a hypoglutamatergic disorder? Relevance of glutamate – serotonin interactions for pharmacotherapy , 1998, Journal of Neural Transmission.

[69]  M. Verity.  Oxidative damage and repair in the developing nervous system. , 1994, Neurotoxicology.

[70]  J. Olney.  Glutamate, a Neurotoxic Transmitter , 1989, Journal of child neurology.

[71]  H. DeLuca,et al.  1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[72]  Yan Zhao,et al.  Effects of maternal oral administration of monosodium glutamate at a late stage of pregnancy on developing mouse fetal brain , 1997, Brain Research.

[73]  G. Anderson.  The potential role for emergence in autism , 2008, Autism research : official journal of the International Society for Autism Research.

[74]  E. Anyanwu,et al.  Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A , 2002, Journal of Neuroimmunology.

[75]  J. Rothstein,et al.  Distribution of Glutamate Transporter Subtypes During Human Brain Development , 1997, Journal of neurochemistry.

[76]  Michael A. Rogawski,et al.  Molecular targets for antiepileptic drug development , 2011, Neurotherapeutics.

[77]  O. Strunecký,et al.  Fluoride plus aluminum: useful tools in laboratory investigations, but messengers of false information. , 2002, Physiological research.

[78]  B. McEwen,et al.  The role of N‐methyl‐D‐asparate receptors in neurogenesis , 2006, Hippocampus.

[79]  T. Burbacher,et al.  Changes in the number of astrocytes and microglia in the thalamus of the monkey Macaca fascicularis following long-term subclinical methylmercury exposure. , 1996, Neurotoxicology.

[80]  Thomas Clarkson,et al.  Comparison of Blood and Brain Mercury Levels in Infant Monkeys Exposed to Methylmercury or Vaccines Containing Thimerosal , 2005, Environmental health perspectives.

[81]  T. Jones,et al.  Enhanced adrenomedullary response and increased susceptibility to neuroglycopenia: mechanisms underlying the adverse effects of sugar ingestion in healthy children. , 1995, The Journal of pediatrics.

[82]  V. Singh,et al.  Circulating autoantibodies to neuronal and glial filament proteins in autism. , 1997, Pediatric neurology.

[83]  H. Nakanishi,et al.  Involvement of enhanced sensitivity of N-methyl-d-aspartate receptors in vulnerability of developing cortical neurons to methylmercury neurotoxicity , 2001, Brain Research.

[84]  Shijie Jin,et al.  Tumor Necrosis Factor-α Induces Neurotoxicity via Glutamate Release from Hemichannels of Activated Microglia in an Autocrine Manner* , 2006, Journal of Biological Chemistry.

[85]  G. Anderson,et al.  Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder , 2005, Biological Psychiatry.

[86]  I. Rapin,et al.  Autistic regression and disintegrative disorder: how important the role of epilepsy? , 1995, Seminars in pediatric neurology.

[87]  J. Hughes,et al.  The neuroprotective effects of the recombinant interleukin–1 receptor antagonist rhIL–1ra after excitotoxic stimulation with kainic acid and its relationship to the amyloid precursor protein gene , 1998, Journal of the Neurological Sciences.

[88]  David A. Geier,et al.  A prospective assessment of porphyrins in autistic disorders: A potential marker for heavy metal exposure , 2006, Neurotoxicity Research.

[89]  L. Sikich,et al.  Early Pharmacological Treatment of Autism: A Rationale for Developmental Treatment , 2007, Biological Psychiatry.

[90]  J. Pevsner,et al.  Postmortem brain abnormalities of the glutamate neurotransmitter system in autism , 2001, Neurology.

[91]  J García-Estrada,et al.  Astrocytic and microglia cells reactivity induced by neonatal administration of glutamate in cerebral cortex of the adult rats , 2002, Journal of neuroscience research.

[92]  H. Cohly,et al.  Immunological findings in autism. , 2005, International review of neurobiology.

[93]  K. Ishikawa,et al.  Neonatal glutamate can destroy the hippocampal CA1 structure and impair discrimination learning in rats , 1993, Brain Research.

[94]  Rena Li,et al.  Target Depletion of Distinct Tumor Necrosis Factor Receptor Subtypes Reveals Hippocampal Neuron Death and Survival through Different Signal Transduction Pathways , 2002, The Journal of Neuroscience.

[95]  P. Shashidharan,et al.  Glutamate Dehydrogenase Deficiency in Cerebellar Degenerations: Clinical, Biochemical and Molecular Genetic Aspects , 1993, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[96]  P. Brachet,et al.  Synthesis of 1,25‐dihydroxyvitamin D3 by rat brain macrophages in vitro , 1994, Journal of neuroscience research.

[97]  J. Bourre,et al.  Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. , 2006, The journal of nutrition, health & aging.

[98]  J. Olney.  Brain Lesions, Obesity, and Other Disturbances in Mice Treated with Monosodium Glutamate , 1969, Science.

[99]  V. Perry,et al.  Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease , 2003, The European journal of neuroscience.

[100]  J. Egger,et al.  Glutamate in pyridoxine-dependent epilepsy: neurotoxic glutamate concentration in the cerebrospinal fluid and its normalization by pyridoxine. , 1994, Pediatrics.

[101]  B. Weiss,et al.  Methylmercury developmental neurotoxicity: a comparison of effects in humans and animals. , 1990, Neurotoxicology and teratology.

[102]  M. Wallis,et al.  Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. , 2006, Child: care, health and development.

[103]  H. Hotta,et al.  Detection of measles virus nucleoprotein mRNA in autopsied brain tissues. , 1995, The Journal of general virology.

[104]  B. Neville.  Magnetoencephalographic Patterns of Epileptiform Activity in Children With Regressive Autism Spectrum Disorders , 1999, Pediatrics.

[105]  C. Beas-Zárate,et al.  Neonatal exposure to monosodium l-glutamate induces loss of neurons and cytoarchitectural alterations in hippocampal CA1 pyramidal neurons of adult rats , 2002, Brain Research.

[106]  M. Chez,et al.  Memantine as Adjunctive Therapy in Children Diagnosed With Autistic Spectrum Disorders: An Observation of Initial Clinical Response and Maintenance Tolerability , 2007, Journal of child neurology.

[107]  Y. Adachi,et al.  Effect of Candida albicans cell wall glucan as adjuvant for induction of autoimmune arthritis in mice. , 2005, Journal of autoimmunity.

[108]  J. Cannell,et al.  Autism and vitamin D. , 2008, Medical hypotheses.

[109]  S. Milstien,et al.  Cerebrospinal fluid and serum markers of inflammation in autism. , 2005, Pediatric neurology.

[110]  S. Budd,et al.  Mitochondria and neuronal survival. , 2000, Physiological reviews.

[111]  J. Green,et al.  Immune Response to Dietary Proteins, Gliadin and Cerebellar Peptides in Children with Autism , 2004, Nutritional neuroscience.

[112]  Michael V. Johnston,et al.  Neurotransmitters and vulnerability of the developing brain , 1995, Brain and Development.

[113]  C. Gillberg,et al.  Elevated CSF glutamate in Rett syndrome. , 1992, Neuropediatrics.

[114]  R. C. Collins,et al.  Excitotoxic mechanisms of epileptic brain damage. , 1986, Advances in neurology.

[115]  Thomas Bourgeron,et al.  Mapping autism risk loci using genetic linkage and chromosomal rearrangements , 2007, Nature Genetics.

[116]  H. Koenig,et al.  Capillary NMDA receptors regulate blood-brain barrier function and breakdown , 1992, Brain Research.

[117]  Steven A. Smith,et al.  Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. , 2005, Journal of chemical neuroanatomy.

[118]  M Hornig,et al.  Neurotoxic effects of postnatal thimerosal are mouse strain dependent , 2004, Molecular Psychiatry.

[119]  G. Moore,et al.  Evidence of altered energy metabolism in autistic children , 1999, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[120]  T. Motawi,et al.  Protective effect of vitamin E, beta-carotene and N-acetylcysteine from the brain oxidative stress induced in rats by lipopolysaccharide. , 2001, The international journal of biochemistry & cell biology.

[121]  L. Borjas,et al.  Plasma excitatory amino acids in autism. , 1996, Investigacion clinica.

[122]  B. Frieder,et al.  Prenatal Monosodium Glutamate Causes Long‐Lasting Cholinergic and Adrenergic Changes in Various Brain Regions , 1987, Journal of neurochemistry.

[123]  Axel Benner,et al.  Further characterization of the autism susceptibility locus AUTS1 on chromosome 7q. , 2001, Human molecular genetics.

[124]  A. Williamson,et al.  Overexpression of GluR6 in Rat Hippocampus Produces Seizures and Spontaneous Nonsynaptic Bursting in Vitro , 2000, Neurobiology of Disease.

[125]  M. Fitzgerald,et al.  Plasma Amino Acid Levels in Children with Autism and Their Families , 2003, Journal of autism and developmental disorders.

[126]  P. Ashwood,et al.  The immune response in autism: a new frontier for autism research , 2006, Journal of leukocyte biology.

[127]  Patrick R Hof,et al.  Neuropathological findings in autism. , 2004, Brain : a journal of neurology.

[128]  P. Filipek,et al.  Relative Carnitine Deficiency in Autism , 2004, Journal of autism and developmental disorders.

[129]  V. Perry,et al.  Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease , 2002, Neuroscience.

[130]  C. McDougle,et al.  A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders. , 2004, Journal of child and adolescent psychopharmacology.

[131]  S. Schulz,et al.  Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices , 2002, Biological Psychiatry.

[132]  Children With Autism Spectrum Disorders Guidelines for Early Identification, Screening, and Clinical Management of , 2008 .

[133]  D. Seidner,et al.  Measured versus estimated aluminum content of parenteral nutrient solutions. , 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[134]  U. K. Misra,et al.  Effect of neonatal monosodium glutamate on lipid peroxidation in adult rat brain. , 1995, Neuroreport.

[135]  G. Mengod,et al.  Control of serotonergic neurons in rat brain by dopaminergic receptors outside the dorsal raphe nucleus , 2001, Journal of neurochemistry.

[136]  Afina W Lemstra,et al.  Microglia activation in sepsis: a case-control study , 2007, Journal of Neuroinflammation.

[137]  M. Aschner,et al.  Persistent, differential alterations in developing cerebellar cortex of male and female mice after methylmercury exposure. , 1984, Brain research.

[138]  C. McDougle,et al.  A retrospective study of memantine in children and adolescents with pervasive developmental disorders , 2007, Psychopharmacology.

[139]  Eileen Daly,et al.  In vivo 1H-magnetic resonance spectroscopy study of amygdala-hippocampal and parietal regions in autism. , 2006 .

[140]  M. Aschner,et al.  Modulatory effect of glutathione status and antioxidants on methylmercury-induced free radical formation in primary cultures of cerebral astrocytes. , 2005, Brain research. Molecular brain research.

[141]  R. Lewis,et al.  The role of group I metabotropic glutamate receptors in neuronal excitotoxicity in alzheimer’s disease , 2009, Neurotoxicity Research.

[142]  N. Zisapel,et al.  Melatonin production in infants. , 2002, Pediatric neurology.

[143]  K. Hashimoto,et al.  Reply to: The hyperglutamatergic hypothesis of autism , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[144]  Yan Zhu,et al.  Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. , 2004, The American journal of clinical nutrition.

[145]  P. Rakic,et al.  Orchestration of neuronal migration by activity of ion channels, neurotransmitter receptors, and intracellular Ca2+ fluctuations. , 1998, Journal of neurobiology.

[146]  Masahiko Watanabe,et al.  Functional Change of NMDA Receptors Related to Enhancement of Susceptibility to Neurotoxicity in the Developing Pontine Nucleus , 1998, The Journal of Neuroscience.

[147]  R. Blaylock,et al.  EXCITOTOXICITY: A POSSIBLE CENTRAL MECHANISM IN FLUORIDE NEUROTOXICITY , 2004 .

[148]  M. Berglund,et al.  Longitudinal study of methylmercury and inorganic mercury in blood and urine of pregnant and lactating women, as well as in umbilical cord blood. , 2000, Environmental research.

[149]  D. Jezova,et al.  Changes of Exploratory Behaviour and Its Habituation in Rats Neonatally Treated with Monosodium Glutamate , 1997, Pharmacology Biochemistry and Behavior.

[150]  F. Serajee,et al.  The metabotropic glutamate receptor 8 gene at 7q31: partial duplication and possible association with autism , 2003, Journal of medical genetics.

[151]  H. Lavreysen,et al.  Therapeutic potential of group III metabotropic glutamate receptors. , 2008, Current medicinal chemistry.

[152]  U. Otten,et al.  Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development , 1994, Brain Research.

[153]  P. Gressens,et al.  Arrest of neuronal migration by excitatory amino acids in hamster developing brain. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[154]  J. Patočka,et al.  Fluoride Interactions: From Molecules to Disease , 2007 .

[155]  B. Hyman,et al.  Do defecs in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? , 1993, Trends in Neurosciences.

[156]  Courtney A. Harper,et al.  A genomic screen of autism: evidence for a multilocus etiology. , 1999, American journal of human genetics.

[157]  T. Day,et al.  Systemic administration of interleukin‐1β activates select populations of central amygdala afferents , 2002, The Journal of comparative neurology.

[158]  D. Grayson,et al.  Reelin gene alleles and susceptibility to autism spectrum disorders , 2002, Molecular Psychiatry.

[159]  Y. Ben-Ari,et al.  Limbic seizure and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsy , 1985, Neuroscience.

[160]  J. A. Laurence,et al.  Glial fibrillary acidic protein is elevated in superior frontal, parietal and cerebellar cortices of autistic subjects , 2008, The Cerebellum.

[161]  Samantha A. Stewart.  The effects of benzodiazepines on cognition. , 2005, The Journal of clinical psychiatry.

[162]  M. Herman,et al.  Mechanisms of aluminum-induced neurodegeneration in animals: Implications for Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.

[163]  J. Spollen,et al.  A preliminary trial of ascorbic acid as supplemental therapy for autism , 1993, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[164]  J. Rothstein,et al.  Glutamate Transporter Protein Subtypes Are Expressed Differentially during Rat CNS Development , 1997, The Journal of Neuroscience.

[165]  G P Daston,et al.  Neurotoxicity of sodium fluoride in rats. , 1995, Neurotoxicology and teratology.

[166]  I. Romero,et al.  Transendothelial permeability changes induced by free radicals in an in vitro model of the blood-brain barrier. , 1999, Free radical biology & medicine.

[167]  J. McGrath,et al.  Distribution of the Vitamin D receptor and 1α-hydroxylase in human brain , 2005, Journal of Chemical Neuroanatomy.

[168]  A. Bailey,et al.  Autism as a strongly genetic disorder: evidence from a British twin study , 1995, Psychological Medicine.

[169]  Vijendra K. Singh,et al.  Abnormal Measles-Mumps-Rubella Antibodies and CNS Autoimmunity in Children with Autism , 2002, Journal of Biomedical Science.

[170]  W. Mundy,et al.  Aluminum potentiates glutamate-induced calcium accumulation and iron-induced oxygen free radical formation in primary neuronal cultures. , 1997, Molecular and chemical neuropathology.

[171]  R. Mohney,et al.  Regional Difference in Susceptibility to Lipopolysaccharide-Induced Neurotoxicity in the Rat Brain: Role of Microglia , 2000, The Journal of Neuroscience.

[172]  D. Cohen,et al.  Plasma androgens in autism , 1995, Journal of autism and developmental disorders.

[173]  E. Saliba,et al.  Inflammatory Mediators and Neonatal Brain Damage , 2001, Neonatology.

[174]  C. L. Cox,et al.  Absence of metabotropic glutamate receptor-mediated plasticity in the neocortex of fragile X mice , 2007, Proceedings of the National Academy of Sciences.

[175]  R. Faull,et al.  Cloning and functional expression of alternative spliced variants of the human metabotropic glutamate receptor 8. , 1999, Brain research. Molecular brain research.

[176]  H. Komuro,et al.  Recent advances in cerebellar granule cell migration , 2003, Cellular and Molecular Life Sciences CMLS.

[177]  C. Montero-Menei,et al.  Vitamin D3 inhibits proinflammatory cytokines and nitric oxide production by the EOC13 microglial cell line , 2003, Journal of neuroscience research.

[178]  K. Wada,et al.  Expression of Two Glutamate Transporters, GLAST and EAAT4, in the Human Cerebellum: Their Correlation in Development and Neonatal Hypoxic-lschemic Damage , 1998, Journal of neuropathology and experimental neurology.

[179]  M. Sigman,et al.  The Development of Young Siblings of Children with Autism from 4 to 54 Months , 2007, Journal of autism and developmental disorders.